1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
T for small highly interacting ROIs. This could possibly be because of the more heterogeneous structure of modest extremely interacting ROIs. On the other side, interactions between a lot more distant and big ROIs are better predicted by the model, most likely because of the much more homogenous connectivity.Alternative Modeling ApproachesThe modeling of large-scale brain dynamics primarily based
1
T for small highly interacting ROIs. This could possibly be because of the more heterogeneous structure of modest extremely interacting ROIs. On the other side, interactions between a lot more distant and big ROIs are better predicted by the model, most likely because of the much more homogenous connectivity.Alternative Modeling ApproachesThe modeling of large-scale brain dynamics primarily based
1
T for small highly interacting ROIs. This could possibly be because of the more heterogeneous structure of modest extremely interacting ROIs. On the other side, interactions between a lot more distant and big ROIs are better predicted by the model, most likely because of the much more homogenous connectivity.Alternative Modeling ApproachesThe modeling of large-scale brain dynamics primarily based
1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G
1
Was 0.507 year to 0.793 year.Huang et al. BMC Cancer (2015) 15:Page 4 ofFig. 1 ALDH1 expression in ovarian carcinoma cells and stromal cells. a A poor differentiated ovarian carcinoma showed negative immunostaining in tumor cells for ALDH1, while most of the stromal cells surrounding tumor cells were strongly positive (100?. b High magnitude was used in the same case in A, showing clear negative t
1
D of TB, and DM patients who are responding poorly to anti-TB treatment should be considered and investigated for drug-resistant disease. Further prospective research using a cohort design with adequate follow-up is needed, which includes all known determinants for drug-resistant TB in DM patients so that a better understanding is reached about the interactions between the two diseases.Citation: G